BRIGHTON_LASER_CLINIC_LIM - Accounts


Company registration number 05291121 (England and Wales)
BRIGHTON LASER CLINIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
The Courtyard
Shoreham Road
Upper Beeding
Steyning
West Sussex
BN44 3TN
BRIGHTON LASER CLINIC LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 8
BRIGHTON LASER CLINIC LIMITED
COMPANY INFORMATION
- 1 -
Directors
Dr A D Morris
Dr S Morris
Company number
05291121
Registered office
The Courtyard
Shoreham Road
Upper Beeding
Steyning
West Sussex
BN44 3TN
Accountants
TC Group
The Courtyard
Shoreham Road
Upper Beeding
Steyning
West Sussex
BN44 3TN
BRIGHTON LASER CLINIC LIMITED
BALANCE SHEET
AS AT 31 MARCH 2023
31 March 2023
- 2 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
-
0
4,564
Current assets
Stocks
-
0
1,000
Debtors
4
-
0
114,393
Cash at bank and in hand
71,200
50,109
71,200
165,502
Creditors: amounts falling due within one year
5
(71,199)
(72,258)
Net current assets
1
93,244
Total assets less current liabilities
1
97,808
Provisions for liabilities
6
-
0
(1,141)
Net assets
1
96,667
Capital and reserves
Called up share capital
7
1
1
Profit and loss reserves
-
0
96,666
Total equity
1
96,667
BRIGHTON LASER CLINIC LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2023
31 March 2023
- 3 -

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 26 June 2023 and are signed on its behalf by:
Dr A D Morris
Director
Company Registration No. 05291121
The notes on pages 4 to 8 form part of these financial statements
BRIGHTON LASER CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 4 -
1
Accounting policies
Company information

Brighton Laser Clinic Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Courtyard, Shoreham Road, Upper Beeding, Steyning, West Sussex, BN44 3TN. The principal place of business is 56A Marine Parade, Brighton, East Sussex, United Kingdom, BN2 1PN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Interest income is recognised when it is probable that the economic benefits will flow to the company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding and the effective interest rate applicable.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
10% on cost
Plant and equipment
25% Reducing balance
Fixtures and fittings
25% Reducing balance
Computers
33% on cost
BRIGHTON LASER CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 5 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

BRIGHTON LASER CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

1.11

Hive up

On 31 January 2023 the trade and assets of the company were hived up to Medical Clinics Limited.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
-
0
-
0
BRIGHTON LASER CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 7 -
3
Tangible fixed assets
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
£
Cost
At 1 April 2022
24,097
98,474
15,787
17,711
156,069
Disposals
(24,097)
(98,474)
(15,787)
(17,711)
(156,069)
At 31 March 2023
-
0
-
0
-
0
-
0
-
0
Depreciation
At 1 April 2022
24,097
94,603
15,095
17,710
151,505
Depreciation charged in the year
-
0
805
144
1
950
Eliminated in respect of disposals
(24,097)
(95,408)
(15,239)
(17,711)
(152,455)
At 31 March 2023
-
0
-
0
-
0
-
0
-
0
Carrying amount
At 31 March 2023
-
0
-
0
-
0
-
0
-
0
At 31 March 2022
-
0
3,871
692
1
4,564
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
-
0
6,090
Amounts owed by group undertakings
-
0
47,856
Other debtors
-
0
60,447
-
0
114,393
5
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
1,023
868
Amounts owed to group undertakings
58,199
45,000
Corporation tax
11,977
26,291
Other taxation and social security
-
0
99
71,199
72,258
BRIGHTON LASER CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 8 -
6
Provisions for liabilities
2023
2022
£
£
Deferred tax liabilities
-
0
1,141
7
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Authorised
Ordinary of £1 each
1
1
1
1
Issued and fully paid
Ordinary of £1 each
1
1
1
1
8
Related party transactions

On 31 January 2023 the trade and assets were hived up to parent company Medical Clinics Limited.

9
Parent company

The parent company of Brighton Laser Clinic Limited is Medical Clinics Limited and its registered office is:

The Courtyard

Shoreham Road,

Upper Beeding,

Steyning,

West Sussex,

England,

BN44 3TN

 

The ultimate controlling party is Medical Clinics Limited.

 

The smallest and largest undertaking for which the company is a member and for which group financial statements are prepared is Medical Clinics Limited.

2023-03-312022-04-01false26 June 2023CCH SoftwareCCH Accounts Production 2023.100No description of principal activityDr A D MorrisDr S Morris052911212022-04-012023-03-3105291121bus:Director12022-04-012023-03-3105291121bus:Director22022-04-012023-03-3105291121bus:RegisteredOffice2022-04-012023-03-31052911212023-03-31052911212022-03-3105291121core:LeaseholdImprovements2023-03-3105291121core:PlantMachinery2023-03-3105291121core:FurnitureFittings2023-03-3105291121core:ComputerEquipment2023-03-3105291121core:LeaseholdImprovements2022-03-3105291121core:PlantMachinery2022-03-3105291121core:FurnitureFittings2022-03-3105291121core:ComputerEquipment2022-03-3105291121core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3105291121core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3105291121core:CurrentFinancialInstruments2023-03-3105291121core:CurrentFinancialInstruments2022-03-3105291121core:ShareCapital2023-03-3105291121core:ShareCapital2022-03-3105291121core:RetainedEarningsAccumulatedLosses2023-03-3105291121core:RetainedEarningsAccumulatedLosses2022-03-3105291121core:LeaseholdImprovements2022-04-012023-03-3105291121core:PlantMachinery2022-04-012023-03-3105291121core:FurnitureFittings2022-04-012023-03-3105291121core:ComputerEquipment2022-04-012023-03-31052911212021-04-012022-03-3105291121core:LeaseholdImprovements2022-03-3105291121core:PlantMachinery2022-03-3105291121core:FurnitureFittings2022-03-3105291121core:ComputerEquipment2022-03-31052911212022-03-3105291121bus:PrivateLimitedCompanyLtd2022-04-012023-03-3105291121bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3105291121bus:FRS1022022-04-012023-03-3105291121bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3105291121bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP